Synchronous or metachronous metastatic cutaneous cell carcinoma and lymphoma/cronic lymphocytic leukaemia: Considerations for management

Oral Oncology Reports Pub Date : 2024-12-14 DOI:10.1016/j.oor.2024.100703

Valentina Terenzi , Veronica Clemenzi , Salvatore Martellucci , Andrea Stolfa , Fiorenza Dal Cortivo , Danilo Di Giorgio , Alberto DellAquila , Mattia Di Bartolomeo , Marco Della Monaca , Andrea Battisti , Paolo Priore , Andrea Gallo , Valentino Valentini , Giulio Pagliuca

{"title":"Synchronous or metachronous metastatic cutaneous cell carcinoma and lymphoma/cronic lymphocytic leukaemia: Considerations for management","authors":"Valentina Terenzi , Veronica Clemenzi , Salvatore Martellucci , Andrea Stolfa , Fiorenza Dal Cortivo , Danilo Di Giorgio , Alberto DellAquila , Mattia Di Bartolomeo , Marco Della Monaca , Andrea Battisti , Paolo Priore , Andrea Gallo , Valentino Valentini , Giulio Pagliuca","doi":"10.1016/j.oor.2024.100703","DOIUrl":null,"url":null,"abstract":"<div><div>Cutaneous squamous cell carcinoma is not uncommon in patients affected by malignant lymphoma, mostly in elderly; the contemporary management of these diseases presents some difficulties, since they require different modalities of treatment. Only small case series and single case report are described in literature about synchronous or metachronous metastatic cutaneous cell carcinoma and lymphoma/chronic lymphocytic leukaemia; in addiction, we report our experience in order to illustrate difficulties encountered in the management of these patients. We conclude that these patients need a close follow-up, and that US-guided FNAC and <sup>18</sup>F-fluorodeoxyglucose PET in addiction to MRI are useful for staging. cSCC, having a poorer prognosis, has to be treated first; nevertheless, mortality in these patients is obviously higher than expected in immunocompetent people.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"13 ","pages":"Article 100703"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Oncology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772906024005491","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Cutaneous squamous cell carcinoma is not uncommon in patients affected by malignant lymphoma, mostly in elderly; the contemporary management of these diseases presents some difficulties, since they require different modalities of treatment. Only small case series and single case report are described in literature about synchronous or metachronous metastatic cutaneous cell carcinoma and lymphoma/chronic lymphocytic leukaemia; in addiction, we report our experience in order to illustrate difficulties encountered in the management of these patients. We conclude that these patients need a close follow-up, and that US-guided FNAC and ¹⁸F-fluorodeoxyglucose PET in addiction to MRI are useful for staging. cSCC, having a poorer prognosis, has to be treated first; nevertheless, mortality in these patients is obviously higher than expected in immunocompetent people.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Oral Oncology Reports

CiteScore

0.20

自引率

0.00%

发文量